American Journal of Kidney Diseases
Volume 53, Issue 4 , Pages 617-627, April 2009

Sodium Bicarbonate Therapy for Prevention of Contrast-Induced Nephropathy: A Systematic Review and Meta-analysis

  • Sankar D. Navaneethan, MD, MPH

      Affiliations

    • Department of Nephrology and Hypertension, Cleveland Clinic, Cleveland, OH
    • Corresponding Author InformationAddress correspondence to Sankar D. Navaneethan, MD, MPH, Department of Nephrology and Hypertension, Cleveland Clinic, 9500 Euclid Ave, A51, Cleveland, OH 44195
  • ,
  • Sonal Singh, MD, MPH

      Affiliations

    • Department of Medicine, Wake Forest University School of Medicine, Winston-Salem, NC
  • ,
  • Suresh Appasamy, MD

      Affiliations

    • Department of Medicine, New York Downtown Hospital, New York
  • ,
  • Richard E. Wing, MD

      Affiliations

    • Nephrology Unit, University of Rochester School of Medicine and Dentistry, Rochester, NY
  • ,
  • Ashwini R. Sehgal, MD

      Affiliations

    • Division of Nephrology, MetroHealth Medical Center, Case Western Reserve University, Cleveland, OH

Received 24 April 2008; accepted 27 August 2008. published online 25 November 2008.

Background

Optimal hydration measures to prevent contrast-induced nephropathy are controversial.

Study Design

We conducted a systematic review and meta-analysis using the MEDLINE database (1966 to January 2008), EMBASE (January 2008), and abstracts from conference proceedings.

Setting & Population

Adult patients undergoing contrast procedures.

Selection Criteria for Studies

Randomized controlled trials comparing intravenous hydration with sodium bicarbonate with hydration with intravenous normal saline for prevention of contrast-induced nephropathy.

Intervention

Hydration with intravenous sodium bicarbonate with or without N-acetylcysteine versus hydration with normal saline with or without N-acetylcysteine.

Outcomes

Contrast-induced nephropathy, need for renal replacement therapy, and worsening of heart failure.

Results

Twelve trials (1,854 participants) were included. Sodium bicarbonate significantly decreased the risk of contrast-induced nephropathy (12 trials, 1,652 patients; odds ratio [OR], 0.46; 95% confidence interval [CI], 0.26 to 0.82; I2 = 55.9%) without a significant difference in need for renal replacement therapy (9 trials, 1,215 patients; OR, 0.50; 95% CI, 0.16 to 1.53; I2 = 0%), in-hospital mortality (11 trials, 1,640 patients; OR, 0.51; 95% CI, 0.15 to 1.69), or congestive heart failure compared with controls. Similar results were seen for the risk of contrast-induced nephropathy when sodium bicarbonate was compared with normal saline alone (OR, 0.39; 95% CI, 0.20 to 0.77), but not when sodium bicarbonate/N-acetylcysteine combination was compared with N-acetylcysteine/normal saline combination (OR, 0.68; 95% CI, 0.34 to 1.37). A subgroup analysis limited to published trials showed similar results (OR, 0.26; 95% CI, 0.10 to 0.64; I2 = 63.3%), whereas unpublished studies showed a nonsignificant decrease (OR, 0.85; 95% CI, 0.46 to 1.57; I2 = 25.9%) in risk of contrast-induced nephropathy.

Limitation

Publication bias and heterogeneity.

Conclusion

Hydration with sodium bicarbonate decreases the incidence of contrast-induced nephropathy in comparison to hydration with normal saline without a significant difference in need for renal replacement therapy and in-hospital mortality. Larger studies analyzing patient-centered outcomes are needed.

Index Words: Hydration, sodium bicarbonate, contrast-induced nephropathy, acute renal failure

 

 Originally published online as doi:10.1053/j.ajkd.2008.08.033 on November 25, 2008.

PII: S0272-6386(08)01431-5

doi:10.1053/j.ajkd.2008.08.033

American Journal of Kidney Diseases
Volume 53, Issue 4 , Pages 617-627, April 2009